China Atherosclerosis Therapeutics Market Analysis

China Atherosclerosis Therapeutics Market Analysis


$ 3999

China Atherosclerosis Therapeutics Market was valued at $225 Mn in 2022 and is estimated to reach $393 Mn in 2030, exhibiting a CAGR of 7.2% during the forecast period. The market for atherosclerosis therapeutics is expected to rise as a result of the increasing prevalence of cardiovascular illnesses that have been exacerbated by unhealthy eating habits, sedentary lifestyles, and an aging population worldwide. The top leading pharmaceutical companies presently operating in the industry are Pfizer, Novartis, AstraZeneca, Sanofi, Merck & Co., China Resources Pharmaceutical Group, Huahai Pharmaceutical Group, Jiangsu Hengrui Medicine Co., Qilu Pharmaceutical Co. and Yisheng Pharmaceutical Co.

ID: IN10CNPH434 CATEGORY: Pharmaceuticals GEOGRAPHY: China AUTHOR: Medha Sansanwal

Buy Now

China Atherosclerosis Therapeutics Market Executive Summary

China Atherosclerosis Therapeutics Market was valued at $225 Mn in 2022 and is estimated to reach $393 Mn in 2030, exhibiting a CAGR of 7.2% during the forecast period.

Atherosclerosis causes plaque, a sticky material consisting of calcium, fat, cholesterol, and other components, to accumulate inside the walls of arteries. This buildup increases the risk of serious illnesses such as heart attacks and strokes, which cause blood vessels to narrow or get blocked. Numerous variables, including high blood pressure, high cholesterol, diabetes, obesity, smoking, a family history of heart disease, inactivity, and an unhealthy diet, can lead to atherosclerosis. Numerous medications, including statins, aspirin, and beta-blockers, have demonstrated potential in reducing or halting the progression of atherosclerosis.

The prevalence of carotid atherosclerosis in China, an indicator of atherosclerosis, is 21.0% for carotid plaque, 0.56% for carotid stenosis, and 26.2% for increased intima-media thickness. Gender and age have an impact, with men typically having a larger prevalence than women and higher rates among older persons. Geographically, because risk factors are concentrated in metropolitan areas, prevalence is higher in urban areas. In China, atherosclerosis plays a major role in cardiovascular diseases (CVD), which account for about half of all deaths and include peripheral artery disease, ischemic heart disease, and stroke. Cardiovascular illnesses have a significant financial cost that affects healthcare systems and productivity.

The Phase IIb clinical trial for HMPL-523, an innovative oral CETP inhibitor intended to reduce cardiovascular risk, is presently being advanced by Hutchison MediPharma. Cholesteryl Ester Transfer Protein, or CETP, is essential for lipid metabolism. As a first-in-class inhibitor, HMPL-523 has the potential to entirely alter the approach by which cardiovascular disease is treated. An important step forward in the development of innovative therapeutics for cardiovascular disorders is being made with the ongoing trial, which aims to assess the safety and effectiveness of HMPL-523 in lowering cardiovascular risk.

A Phase II clinical trial has been started by Innovent Therapeutics for IBI-346, an inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9) demonstrating potential. IBI-346 targets PCSK9, a protein known for its function in controlling cholesterol levels, and is specially designed to treat hyperlipidemia and atherosclerosis.

China Atherosclerosis Therapeutics Market Analysis 2022 to 2030

Market Dynamics

Market Growth Drivers

Rising Prevalence of Cardiovascular Disease (CVD): With the largest population in the world, China is dealing with 330 Mn people who suffer from CVD, with atherosclerosis being the main cause of these instances. Rapid urbanization and changes in lifestyle patterns, such as unhealthy eating habits, smoking, and sedentary activity, have been strongly linked to the rise in CVD cases.

Aging Population: The rapidly aging population in China is a major driver of market expansion in the atherosclerosis drug treatment industry. Age-related increases in atherosclerosis susceptibility increase demand for medications that address this problem. According to projections, over 25% of China's population is expected to be over 65 by 2030, which will increase demand for atherosclerosis treatment medications and support the market's growth.

Rising Awareness and Early Diagnosis: As a result of improved screening methods and heightened public awareness of cardiovascular health, atherosclerosis is discovered early, encouraging people to seek treatment sooner rather than later. This early intervention is likely to drive greater demand for medication throughout patient's lives.

Market Restraints

High Cost of Treatment: Accessibility may be limited by the high price of innovative and effective atherosclerosis drugs, especially the most recent biologics. This problem is made more acute in rural areas where access to healthcare is restricted for a significant proportion of the population due to limited insurance coverage and tight healthcare expenditures. A large segment of the population faces accessibility issues because of the high cost of atherosclerosis drug treatment, which operates as a market restraint in China. This is particularly true for rural areas where healthcare budgets and insurance coverage are constrained.

Lack of Awareness and Early Diagnosis: Atherosclerosis and the associated risk factors are not commonly understood among the Chinese community, which could lead to a delayed diagnosis and missed opportunities for early management. Due to this lack of knowledge, the potential market size for opportunities in initial treatment is reduced, which serves as a market restraint.

Compliance and Adherence Issues: Long-term drug adherence is often required for the treatment of atherosclerosis, which can be challenging for some patients who experience adverse effects, forgetfulness, or low motivation. The complexity of managing multiple medications for various health conditions further exacerbates challenges in adherence. The need for long-term medication adherence, along with difficulties like side effects and the difficulty of managing multiple medications, may discourage patient compliance, limiting the market potential for treatment solutions. This presents a market restraint for the atherosclerosis therapeutics market.

Healthcare Policies and Regulatory Landscape

Treatment drug regulations in China are governed by the China National Medical Products Administration (NMPA), which has a thorough drug approval procedure that includes preclinical research, clinical trials, and post-marketing surveillance. The National Healthcare Security Administration (NHSA) decides on reimbursement guidelines and negotiates medication costs with pharmaceutical companies. Strengthening intellectual property protection in the pharmaceutical industry and increasing the coverage of health insurance are two other key objectives of China's healthcare policies.

Competitive Landscape

Key Players

  • Pfizer
  • Novartis
  • AstraZeneca
  • Sanofi
  • Merck & Co.
  • China Resources Pharmaceutical Group
  • Huahai Pharmaceutical Group
  • Jiangsu Hengrui Medicine Co.
  • Qilu Pharmaceutical Co.
  • Yisheng Pharmaceutical Co.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

China Atherosclerosis Therapeutics Market Segmentation

By Therapy

  • Atherosclerosis Medications
  • Cholesterol-lowering Medications
  • Antiplatelet drugs and Anticoagulants
  • Atherosclerosis Beta Blockers
  • Diuretics or Water Pills
  • Angiotensin Converting Enzyme (Ace) Inhibitors
  • Other Atherosclerosis Treatment Therapies

By Surgery

  • Bypass Surgery (Coronary Artery Bypass Grafting (CABG))
  • Angioplasty
  • Atherectomy

By Drug Class

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Manufactured Combination

By End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Clinics
  • Drug stores
  • Retail pharmacies
  • Online pharmacies
  • Other distribution channel

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 06 March 2024
Updated by: Dr. Purav Gandhi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up